|
|
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
/ Unknown statusPhase 1/2 An Open Label Randomized Study to Examine the Safety and Clinical Efficacy of Local Topical Dual Active Preparation for Erectile Dysfunction
VL#FIA3-30 is a preparation intended for topical use, applied on the penis, for the treatment of ED.
100 Clinical Results associated with ADRA1 x NPR
100 Translational Medicine associated with ADRA1 x NPR
0 Patents (Medical) associated with ADRA1 x NPR